CN114805847A - Purification based on spider silk-cationic polypeptide fusion protein and preparation method of underwater adhesion hydrogel - Google Patents

Purification based on spider silk-cationic polypeptide fusion protein and preparation method of underwater adhesion hydrogel Download PDF

Info

Publication number
CN114805847A
CN114805847A CN202210230688.7A CN202210230688A CN114805847A CN 114805847 A CN114805847 A CN 114805847A CN 202210230688 A CN202210230688 A CN 202210230688A CN 114805847 A CN114805847 A CN 114805847A
Authority
CN
China
Prior art keywords
protein
hydrogel
spider silk
solution
expression vector
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202210230688.7A
Other languages
Chinese (zh)
Other versions
CN114805847B (en
Inventor
钱志刚
刘树安
黄盛晨
夏小霞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Jiao Tong University
Original Assignee
Shanghai Jiao Tong University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Jiao Tong University filed Critical Shanghai Jiao Tong University
Priority to CN202210230688.7A priority Critical patent/CN114805847B/en
Publication of CN114805847A publication Critical patent/CN114805847A/en
Application granted granted Critical
Publication of CN114805847B publication Critical patent/CN114805847B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00Processes of treating or compounding macromolecular substances
    • C08J3/02Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
    • C08J3/03Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
    • C08J3/075Macromolecular gels
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43518Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from spiders
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2389/00Characterised by the use of proteins; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/04Oxygen-containing compounds
    • C08K5/15Heterocyclic compounds having oxygen in the ring
    • C08K5/151Heterocyclic compounds having oxygen in the ring having one oxygen atom in the ring
    • C08K5/1545Six-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Dispersion Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Insects & Arthropods (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Polymers & Plastics (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)

Abstract

一种基于蛛丝‑阳离子多肽融合蛋白的纯化及水下粘附水凝胶的制备方法,将重组蛛丝蛋白基因与阳离子多肽的基因融合后连接至表达载体pET28a4构建得到重组表达载体,然后将重组表达载体导入表达宿主细胞中,经过发酵表达以及分离纯化后得到高纯度目的蛋白;再将高纯度目的蛋白的溶液与单宁酸溶液交联反应得到水下黏附水凝胶。本发明使用宿主本身的负电膜蛋白OmpF作为纯化介质,能够大量获得高纯度的融合蛋白,通过与单宁酸物理交联制成性能优良的水下粘附水凝胶,可批量纯化且降低成本。

Figure 202210230688

A method for purifying a spider silk-cationic polypeptide fusion protein and preparing a hydrogel for underwater adhesion, the recombinant spider silk protein gene and the cationic polypeptide gene are fused and then connected to an expression vector pET28a4 to construct a recombinant expression vector, and then the recombinant expression vector is constructed. The recombinant expression vector is introduced into the expression host cell, and the high-purity target protein is obtained after fermentative expression, separation and purification; and then the solution of the high-purity target protein is cross-linked with the tannic acid solution to obtain the underwater adhesion hydrogel. The present invention uses the negatively charged membrane protein OmpF of the host itself as a purification medium, and can obtain a large amount of high-purity fusion proteins, and is physically cross-linked with tannic acid to prepare an underwater adhesive hydrogel with excellent performance, which can be purified in batches and reduce costs. .

Figure 202210230688

Description

基于蛛丝-阳离子多肽融合蛋白的纯化及水下粘附水凝胶的 制备方法Purification of spider silk-cationic polypeptide fusion protein and preparation of underwater adhesive hydrogel

技术领域technical field

本发明涉及的是一种生物工程领域的技术,具体是一种基于蛛丝-阳离子多肽融合蛋白的纯化及水下粘附水凝胶的制备方法。The invention relates to a technology in the field of bioengineering, in particular to a method for purifying a spider silk-cationic polypeptide fusion protein and preparing an underwater adhesive hydrogel.

背景技术Background technique

在材料科学领域,制备具有水下高粘附性能的水凝胶材料一直是研究的热点和难点。天然高分子水凝胶如蛋白、壳聚糖、纤维素等由于其比化学高分子水凝胶具有更好的生物相容性及可调控的降解性因此备受关注。目前制备具水下粘附性能的天然高分子水凝胶的主流方法是通过化学枝接基团或物理掺合离子等手段对蛋白材料进行修饰,以创制出性能增强的蛋白水凝胶,但往往因稳定性不足且非天然修饰基团的生物相容性不足以致于限制了其应用范围。本发明利用基因工程和发酵工程技术直接生产出天然多肽修饰的融合蛋白而无需额外对水凝胶进行化学或物理修饰,避免了有细胞毒性的非天然组分并且解决了融合正电及疏水多肽的重组蛛丝蛋白难以用镍亲和层析纯化的问题,极大地方便了工业生产和使用,该方式制得的重组蛋白水凝胶可以实现常见材料例如铝、塑料和玻璃等以及组织器官表面快速,稳定的粘附性,尤其是水下环境的即时粘附,具有广阔的应用前景和价值。In the field of materials science, the preparation of hydrogel materials with high underwater adhesion has always been a hot and difficult research topic. Natural polymer hydrogels such as protein, chitosan, and cellulose have attracted much attention due to their better biocompatibility and tunable degradation than chemical polymer hydrogels. The current mainstream method for preparing natural polymer hydrogels with underwater adhesion properties is to modify protein materials by means of chemical grafting groups or physical blending ions to create protein hydrogels with enhanced properties. Often, its application range is limited due to insufficient stability and insufficient biocompatibility of non-natural modifying groups. The present invention utilizes genetic engineering and fermentation engineering technology to directly produce fusion proteins modified by natural polypeptides without additional chemical or physical modification of hydrogels, avoids cytotoxic non-natural components and solves the problem of fusion of positively charged and hydrophobic polypeptides The problem that the recombinant spider silk protein is difficult to purify by nickel affinity chromatography greatly facilitates industrial production and use. The recombinant protein hydrogel prepared in this way can realize common materials such as aluminum, plastic and glass, as well as the surface of tissues and organs. Fast and stable adhesion, especially instant adhesion in underwater environment, has broad application prospects and value.

发明内容SUMMARY OF THE INVENTION

本发明针对现有基于天然高分子的粘附类水凝胶制备相对复杂,性能不稳定以及融合有阳离子肽段的重组蛛丝蛋白难以纯化或纯度不高的问题,提出一种基于蛛丝-阳离子多肽融合蛋白的纯化及水下粘附水凝胶的制备方法,使用宿主本身的负电膜蛋白OmpF作为纯化介质,能够大量获得高纯度的融合蛋白,通过与单宁酸物理交联制成性能优良的水下粘附水凝胶,可批量纯化且降低成本。Aiming at the problems that the existing adhesive hydrogels based on natural macromolecules are relatively complex in preparation, unstable in performance and difficult to purify or have low purity of recombinant spider silk proteins fused with cationic peptide segments, the present invention proposes a spider silk-based Purification of cationic polypeptide fusion protein and preparation method of underwater adhesive hydrogel, using the host's own negatively charged membrane protein OmpF as the purification medium, a large amount of high-purity fusion protein can be obtained, and the performance is obtained by physical cross-linking with tannic acid. Excellent underwater adhering hydrogel for batch purification and cost reduction.

本发明是通过以下技术方案实现的:The present invention is achieved through the following technical solutions:

本发明涉及一种基于蛛丝-阳离子多肽融合蛋白的水下粘附水凝胶的制备方法,将重组蛛丝蛋白基因与阳离子多肽的基因融合后连接至表达载体pET28a4构建得到重组表达载体,然后将重组表达载体导入表达宿主细胞中,经过发酵表达以及分离纯化后得到高纯度目的蛋白;再将高纯度目的蛋白的溶液与单宁酸溶液交联反应得到水下粘附水凝胶。The invention relates to a preparation method of an underwater adhesive hydrogel based on a spider silk-cationic polypeptide fusion protein. The recombinant spider silk protein gene and the cationic polypeptide gene are fused and then connected to an expression vector pET28a4 to construct a recombinant expression vector, and then the recombinant expression vector is constructed. The recombinant expression vector is introduced into the expression host cell, and the high-purity target protein is obtained after fermentative expression, separation and purification; and then the solution of the high-purity target protein is cross-linked with the tannic acid solution to obtain the underwater adhesion hydrogel.

所述的重组蛛丝蛋白基因是指:金丝网蛛(Trichonephila clavipes)牵引丝蛋白MaSpI核心重复序列重复4、8、16、32和64次的蛋白,其中:MaSpI核心重复序列的氨基酸序列如 SEQ ID No.1所示。Described recombinant spider silk protein gene refers to: golden silk spider (Trichonephila clavipes) traction silk protein MaSpI core repeating sequence repeats 4, 8, 16, 32 and 64 times protein, wherein: the amino acid sequence of MaSpI core repeating sequence is as follows: shown in SEQ ID No. 1.

所述的构建是指将合成的阳离子多肽基因通过限制性核酸内切酶BamHI HF和NcoI HF 进行双酶切后,通过T4 DNA连接酶连接至表达载体pET28a4得到重组蛛丝蛋白的表达载体。The construction refers to double digestion of the synthesized cationic polypeptide gene by restriction endonucleases BamHI HF and NcoI HF, and then ligated to the expression vector pET28a4 by T4 DNA ligase to obtain the expression vector of recombinant spider silk protein.

所述的表达载体pET28a4是指:在市售pET28a(+)表达载体的多克隆位点修饰添加BamHI限制性酶切位点,其采用但不限于《大肠杆菌无膜隔室的形成和功能化》(Wei SP,Qian ZG,Hu CF,Pan F,Chen MT,Lee SY,XiaXX.“Formation and functionalization ofmembraneless compartments in Escherichia coli.”Nat Chem Biol,2020,16(10):1143-1148.)中记载的技术实现。Described expression vector pET28a4 refers to: modify and add BamHI restriction enzyme site in the multi-cloning site of commercially available pET28a(+) expression vector, it adopts but is not limited to "Escherichia coli Formation and functionalization of membraneless compartment. (Wei SP, Qian ZG, Hu CF, Pan F, Chen MT, Lee SY, XiaXX. "Formation and functionalization of membraneless compartments in Escherichia coli." Nat Chem Biol, 2020, 16(10):1143-1148.) documented technical implementation.

所述的阳离子多肽包括但不限于LL37、protamine多肽、多聚赖氨酸、多聚精氨酸、多聚组氨酸、富含赖氨酸、富含精氨酸、富含组氨酸等的带正电荷多肽。Described cationic polypeptides include but are not limited to LL37, protamine polypeptides, polylysine, polyarginine, polyhistidine, lysine-rich, arginine-rich, histidine-rich, etc. of positively charged polypeptides.

所述的LL37的氨基酸序列如SEQ ID No.2所示,即:The amino acid sequence of described LL37 is shown in SEQ ID No.2, namely:

LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES(来自数据库:PBD),其密码子优化过后的核苷酸序列如SEQ ID No.3所示,即:5’- CTGCTGGGCGATTTCTTCCGCAAAAGCAAAGAAAAAATCGGCAAAGAATTCAAACGCATCGTTCAGCGC ATCAAAGATTTCCTGCGCAATCTGGTTCCGCGCACCGAAAGC-3’。LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES (from database: PBD), its codon-optimized nucleotide sequence is shown in SEQ ID No. 3, namely: 5'-CTGCTGGGCGATTTCTTCCGCAAAAGCAAAGAAAAAATCGGCAAAGAATTCAAACGCATCGTTCAGCGC ATCAAAGATTTCCTGCGCAATCTGGTTCCGCGCACCGAAAGC-3'.

所述的protamine多肽的氨基酸序列如SEQ ID No.4所示,即:The amino acid sequence of the protamine polypeptide is shown in SEQ ID No.4, namely:

RSQSRSRYYRQRQRSRRRRRRS(来自数据库:NCBI),其密码子优化过后的核苷酸序列如SEQ ID No.5所示,即:5’- CGTAGCCAGAGCCGTAGCCGTTACTACCGTCAGCGTCAGCGTAGCCGTCGTCGTCGCCGTCGTAGC-3’。RSQSRSRYYRQRQRSRRRRRRS (from database: NCBI), its codon-optimized nucleotide sequence is shown in SEQ ID No. 5, namely: 5'-CGTAGCCAGAGCCGTAGCCGTTACTACCGTCAGCGTCAGCGTAGCCGTCGTCGTCGCCGTCGTAGC-3'.

所述的表达宿主为E.coli BL21(DE3)和E.coli BL21(DE3)plysS,所用的蛋白表达诱导剂为异丙基硫代半乳糖苷(IPTG)。The expression hosts were E. coli BL21 (DE3) and E. coli BL21 (DE3) plysS, and the used protein expression inducer was isopropyl thiogalactoside (IPTG).

所述的分离纯化,具体包括:把表达有融合蛋白的大肠杆菌湿菌体以1:10质量体积比充分重悬于BufferA中再通过高压匀浆仪高压800~1000bar压力破壁释放胞内物质。将破壁后的破菌液调节pH至Z,即融合了多肽Y的重组蛛丝蛋白与破菌释放的负电膜蛋白OmpF 结合复合物的等电点,使用磁力搅拌器搅拌30min,随后离心弃上清取沉淀再重悬于BufferA 中,充分重悬洗涤重复3次,离心后将沉淀充分重悬于Buffer B中离心取上清,将上清进行硫酸铵沉淀,再将该沉淀重悬于蒸馏水中,离心取上清,最后若需要完全纯水溶解的蛋白可选用疏水柱过滤该上清取流出液。The separation and purification specifically includes: fully resuspending the Escherichia coli wet cells expressing the fusion protein in Buffer A at a mass-to-volume ratio of 1:10, and then breaking the walls through a high-pressure homogenizer at a pressure of 800-1000 bar to release intracellular substances . Adjust the pH of the broken bacteria solution after breaking the wall to Z, that is, the isoelectric point of the binding complex of the recombinant spidroin protein fused with polypeptide Y and the negatively charged membrane protein OmpF released by the broken bacteria, stir with a magnetic stirrer for 30 min, and then discard by centrifugation. The supernatant was collected and resuspended in Buffer A, and the washing was repeated 3 times. After centrifugation, the precipitate was fully resuspended in Buffer B. The supernatant was obtained by centrifugation. Distilled water, centrifuged to take the supernatant, and finally, if the protein dissolved in completely pure water is required, the supernatant can be filtered with a hydrophobic column to take the effluent.

所述的分离纯化,利用重组蛛丝蛋白的正电嵌段和负电的OmpF膜蛋白结合,将pH调节至该结合物的等电点Z使其沉淀粗纯,经漂洗后溶解于Buffer B中,利用Buffer B中PEI 的强正电荷结合该负电杂蛋白OmpF使其沉淀,而重组蛛丝蛋白仍存在于上清中实现了进一步纯化。For the separation and purification, the positively charged block of recombinant arachnid protein is combined with the negatively charged OmpF membrane protein, and the pH is adjusted to the isoelectric point Z of the conjugate to make it precipitate crudely pure, and after rinsing, it is dissolved in Buffer B. , using the strong positive charge of PEI in Buffer B to bind the negatively charged hybrid protein OmpF to make it precipitate, while the recombinant spider silk protein still exists in the supernatant to achieve further purification.

所述的等电点Z=多肽Y的等电点×其在复合物中含量占比+OmpF等电点4.5×其在复合物中的占比。Said isoelectric point Z=isoelectric point of polypeptide Y×its content ratio in the complex+OmpF isoelectric point 4.5×its proportion in the complex.

所述的BufferA为含有10mM Tris和50mM NaCl的水溶液,其pH值与等电点值Z 相同。The Buffer A is an aqueous solution containing 10 mM Tris and 50 mM NaCl, and its pH is the same as the isoelectric point Z.

所述的Buffer B为含有50mM Tris,500mM NaCl,8M尿素,PEI10kd(2%m/v),的Triton X-100(1.5%v/v)的水溶液(pH 4.5)。The Buffer B is an aqueous solution (pH 4.5) containing 50 mM Tris, 500 mM NaCl, 8 M urea, PEI 10 kd (2% m/v), and Triton X-100 (1.5% v/v).

所述的硫酸铵沉淀,具体是指:将硫酸铵粉末加入到上清至40%饱和度,此时蛋白溶液会产生聚集沉淀,25℃下12000rpm(×21235g)离心30min取沉淀。The ammonium sulfate precipitation specifically refers to: adding ammonium sulfate powder to the supernatant to 40% saturation, at this time the protein solution will produce aggregated precipitate, and centrifuge at 12000rpm (×21235g) for 30min at 25°C to get the precipitate.

所述的疏水柱填料为Phenyl Beeds 6FF,过疏水柱的目的是去除残余的TritonX-100。The hydrophobic column packing is Phenyl Beeds 6FF, and the purpose of passing through the hydrophobic column is to remove residual TritonX-100.

所述的高纯度目的蛋白的溶液是指:将冻干的蛋白溶解于90mM LiBr溶液中,配置100mg/ml的蛋白溶液。The high-purity target protein solution refers to: dissolving the lyophilized protein in a 90 mM LiBr solution to prepare a 100 mg/ml protein solution.

所述的交联反应是指:按1:1体积比将高纯度目的蛋白的溶液逐渐滴加到单宁酸溶液中,滴加完毕后使用搅拌棒搅拌,即可形成粘附于搅拌棒的水凝胶。The cross-linking reaction refers to: gradually drop the high-purity target protein solution into the tannic acid solution at a volume ratio of 1:1, and stir with a stirring bar after the dropwise addition, so as to form a solution that adheres to the stirring bar. Hydrogels.

本发明涉及上述方法制备得到的水下粘附水凝胶,其宏观形态为柔软可塑形的浅棕色固体,微观形态为丰富的孔洞结构,水下粘附强度为1~100kpa。The invention relates to an underwater adhesive hydrogel prepared by the above method, which has a macroscopic shape of a soft and plastic light brown solid, a microscopic shape of a rich pore structure, and an underwater adhesion strength of 1-100 kPa.

技术效果technical effect

与现有技术相比,本发明利用表达宿主本身的负电OmpF蛋白为纯化介质的纯化方式避免了柱层析纯化方式的上料体积限制,耗材昂贵,流程复杂缓慢,难以放大等问题,可将整个纯化流程时间缩短至亲和层析纯化的十分之一,耗材成本极低,操作便捷且可工业批量放大;本发明制得的天然多肽修饰的蛛丝融合蛋白对比蛛丝蛋白在同等水凝胶制备和使用条件下展示出更高的粘附性能,且无其他粘附水凝胶中的非天然致毒成分,对组织器官表面和常见材料如塑料,金属等均具有快速,稳定的粘附性。Compared with the prior art, the present invention uses the negatively charged OmpF protein of the expression host itself as the purification medium to avoid the limitation of the loading volume of the column chromatography purification method, the expensive consumables, the complicated and slow flow process, and the difficulty in amplification. The entire purification process time is shortened to one tenth of that of affinity chromatography purification, the cost of consumables is extremely low, the operation is convenient, and it can be scaled up in industrial batches; The gel exhibits higher adhesion performance under the conditions of preparation and use, and has no non-natural toxic components in other adhesion hydrogels, and has fast and stable adhesion to the surface of tissues and organs and common materials such as plastics, metals, etc. Attachment.

附图说明Description of drawings

图1为实施例中蛛丝-阳离子多肽融合蛋白的SDS-PAGE图;Fig. 1 is the SDS-PAGE figure of spider silk-cationic polypeptide fusion protein in the embodiment;

图中:#1为LL37-MaSpI16蛋白,#2为protamine-MaSpI16蛋白;In the figure: #1 is LL37-MaSpI16 protein, #2 is protamine-MaSpI16 protein;

图2为本发明中蛛丝-阳离子多肽融合蛋白的纯化流程示意图;Fig. 2 is a schematic diagram of the purification process of spider silk-cationic polypeptide fusion protein in the present invention;

图3为实施例LL37-MaSpI16蛋白纯化流程的SDS-PAGE图;Fig. 3 is the SDS-PAGE figure of the purification process of the LL37-MaSpI16 protein of the embodiment;

图中:#P0显示LL37-MaSpI16蛋白和OmpF蛋白结合而沉淀实现粗纯,#P1显示 OmpF蛋白被PEI10kDa所竞争结合沉淀分离,释放出#S2所示的LL37-MaSpI16蛋白。In the figure: #P 0 shows that LL37-MaSpI16 protein is combined with OmpF protein and precipitates to achieve crude purity, #P 1 shows that OmpF protein is competed by PEI 10kDa for binding and precipitation, releasing LL37-MaSpI16 protein shown in #S 2 .

图4为实施例LL37-MaSpI16 TA水凝胶实物照片,TA指代单宁酸;Fig. 4 is the actual photo of embodiment LL37-MaSpI16 TA hydrogel, TA refers to tannic acid;

图5为实施例LL37-MaSpI16 TA水凝胶,protamine-MaSpI16 TA水凝胶以及对照MaSpI16 TA水凝胶的扫描电子显微镜照片,制备水凝胶采用的蛋白浓度为100mg/ml,TA浓度为200mg/ml,两者体积比为1:1;Figure 5 is a scanning electron microscope photograph of Example LL37-MaSpI16 TA hydrogel, protamine-MaSpI16 TA hydrogel and control MaSpI16 TA hydrogel, the protein concentration used for preparing the hydrogel is 100mg/ml, and the TA concentration is 200mg /ml, the volume ratio of the two is 1:1;

图6为实施例LL37-MaSpI16 TA水凝胶,protamine-MaSpI16 TA水凝胶以及对照MaSpI16 TA水凝胶的流变学实验数据,制备水凝胶采用的蛋白浓度为100mg/ml,TA浓度为200mg/ml,两者体积比为1:1;Figure 6 is the rheological experimental data of Example LL37-MaSpI16 TA hydrogel, protamine-MaSpI16 TA hydrogel and control MaSpI16 TA hydrogel, the protein concentration used for preparing the hydrogel is 100 mg/ml, and the TA concentration is 200mg/ml, the volume ratio of the two is 1:1;

图中:G’为弹性模量,G”为损耗模量;In the figure: G’ is the elastic modulus, G” is the loss modulus;

图7为实施例LL37-MaSpI16 TA水凝胶,protamine-MaSpI16 TA水凝胶以及对照MaSpI16 TA水凝胶水下粘附性能测试数据示意图,制备水凝胶采用的蛋白浓度为100mg/ml, TA浓度为100~300mg/ml,两者体积比为1:1;Figure 7 is a schematic diagram of the test data of underwater adhesion performance of Example LL37-MaSpI16 TA hydrogel, protamine-MaSpI16 TA hydrogel and control MaSpI16 TA hydrogel, the protein concentration used for preparing the hydrogel is 100mg/ml, TA The concentration is 100~300mg/ml, and the volume ratio of the two is 1:1;

图8为蛛丝-阳离子多肽融合蛋白粘附应用示意图。Figure 8 is a schematic diagram of the adhesion application of spider silk-cationic polypeptide fusion protein.

具体实施方式Detailed ways

本实施例包括以下步骤:This embodiment includes the following steps:

步骤1)构建目标蛋白表达载体,将该表达载体导入大肠杆菌E.coli BL21(DE3)中实现表达生产的方法,具体包括:Step 1) construct a target protein expression vector, and import the expression vector into Escherichia coli E.coli BL21 (DE3) to realize the method for expression production, specifically including:

1.1)将合成的阳离子多肽基因通过限制性核酸内切酶BamHI HF和NcoIHF进行双酶切后,通过T4 DNA连接酶连接至表达载体pET28a4-MaSpI16上构建得到LL37-MaSpI16融合蛋白的表达载体和protamine-MaSpI16融合蛋白的表达载体。1.1) After double digestion of the synthesized cationic polypeptide gene by the restriction endonucleases BamHI HF and NcoIHF, the expression vector and protamine of the LL37-MaSpI16 fusion protein were constructed by connecting to the expression vector pET28a4-MaSpI16 by T4 DNA ligase. - Expression vector for MaSpI16 fusion protein.

1.2)对于LL37-MaSpI16融合蛋白而言,其表达生产流程为:将表达载体pET28a4-LL37-MaSpI16转化入表达宿主细胞后,将该表达宿主细胞在含卡那霉素(50mg/L)的4mL LB试管培养基中37℃培养6~8h后,接种在4~6个含卡那霉素(50mg/L)的50mL R/2培养基的小摇瓶中37℃培养8h左右之后,将其全部转入含卡那霉素的2L R/2培养基发酵罐中, 37℃培养至OD600为40左右时,加入浓度为1M的IPTG溶液2ml,16℃诱导表达 12~16h后收菌。1.2) For the LL37-MaSpI16 fusion protein, its expression production process is: after the expression vector pET28a4-LL37-MaSpI16 is transformed into the expression host cell, the expression host cell is placed in 4mL containing kanamycin (50mg/L). After culturing at 37°C for 6-8h in LB test tube medium, inoculate 4-6 small shake flasks containing kanamycin (50mg/L) in 50mL R/2 medium for about 8h at 37°C, All were transferred into a 2L R/2 medium fermenter containing kanamycin, cultured at 37°C to an OD600 of about 40, added 2ml of IPTG solution with a concentration of 1M, induced expression at 16°C for 12-16h and harvested.

对于protamine-MaSpI16融合蛋白而言,其表达生产流程为:将表达载体pET28a4-protamine-MaSpI16转化入表达宿主细胞后,将该表达宿主细胞接种于含卡那霉素(50mg/L) 的4mL LB试管,37℃,220rpm过夜培养。以1%的接种量,将上述菌液转接至100mL 含卡那霉素(50mg/L)的LB液体培养基中,37℃,220rpm培养3~4h,至菌液OD600达到 3~4时,将上述菌液全部添加至含卡那霉素(50mg/L)的800ml TB液体培养基中,37℃, 220rpm培养。当OD600达到6~8时诱导表达,添加0.9mL 1M IPTG进行诱导,诱导条件为16℃、220rpm、20h。For the protamine-MaSpI16 fusion protein, the expression production process is as follows: after the expression vector pET28a4-protamine-MaSpI16 is transformed into the expression host cell, the expression host cell is inoculated into 4mL LB containing kanamycin (50mg/L). Tubes, incubated overnight at 37°C, 220 rpm. With 1% of the inoculum, the above bacterial liquid was transferred to 100 mL of LB liquid medium containing kanamycin (50 mg/L), and cultured at 37°C and 220 rpm for 3 to 4 hours, until the OD600 of the bacterial liquid reached 3 to 4. , all the above bacterial liquids were added to 800ml TB liquid medium containing kanamycin (50mg/L), and cultured at 37°C and 220rpm. When the OD600 reached 6-8, the expression was induced, and 0.9 mL of 1M IPTG was added for induction. The induction conditions were 16 °C, 220 rpm, and 20 h.

所述的克隆宿主大肠杆菌E.coli DH5α,表达宿主E.coli BL21(DE3);表达质粒pET28a4;BamHI&NcoI限制性内切酶,T4 DNA连接酶;卡那霉素,氯霉素;LB培养基, R/2培养基。The cloned host E.coli DH5α, the expression host E.coli BL21 (DE3); the expression plasmid pET28a4; BamHI&NcoI restriction endonucleases, T4 DNA ligase; kanamycin, chloramphenicol; LB medium , R/2 medium.

所述的LB培养基(每升)的组分含量为:10g/L胰蛋白胨、5g/L酵母粉和10g/L氯化钠,高压蒸汽灭菌121℃,20min。The component content of the LB medium (per liter) is: 10 g/L tryptone, 5 g/L yeast powder and 10 g/L sodium chloride, autoclaved at 121° C. for 20 min.

所述的TB培养基(每升)的组分含量为:13.4g/L胰蛋白胨,26.7g/L酵母提取物,5.6g/L甘油以配置组分A,搅拌混匀后每个2L摇瓶中装入720ml组分A,高压蒸汽灭菌 121℃,20min。组分B磷酸盐缓冲液:23.1g/L KH2PO4,164.3g/L K2HPO4·3H2O,高压蒸汽灭菌121℃,20min。使用前在每720mL组分A中添加组分B 80mL。The component content of the TB medium (per liter) is: 13.4g/L tryptone, 26.7g/L yeast extract, 5.6g/L glycerol to configure component A, and after stirring and mixing, each 2L shakes Fill the bottle with 720 ml of component A, and sterilize by autoclaving at 121° C. for 20 min. Component B phosphate buffer: 23.1g/L KH2PO4, 164.3g/L K2HPO4·3H2O, autoclaved at 121°C for 20min. Add 80 mL of Part B to every 720 mL of Part A before use.

所述的R/2培养基(每升)的组分含量为:2g/L(NH4)2SO4、6.75g/L KH2PO4、0.85g/L柠檬酸、Trace metal 5mL/L,该培养基经氢氧化钾调节pH至6.8,高压蒸汽灭菌 121℃,20min。The component content of the described R/2 medium (per liter) is: 2g/L (NH4)2SO4, 6.75g/L KH2PO4, 0.85g/L citric acid, Trace metal 5mL/L, the medium is hydrogenated The pH was adjusted to 6.8 with potassium oxide, and sterilized by autoclaving at 121 °C for 20 min.

步骤2)收获发酵菌体后的分离纯化:把表达有融合蛋白LL37-MaSpI的大肠杆菌湿菌体以1:10质量体积比充分重悬于BufferA中调节pH至Z,再通过高压匀浆仪高压 800~1000bar压力破壁释放胞内物质。破壁后的破菌液调节pH至Z,随后离心弃上清取沉淀置于搅拌台上搅拌,使其充分重悬于BufferA中,随后25℃下12000rpm(×21235g)离心 20min取沉淀,此步骤起洗涤作用,共重复3次。将洗涤3遍后的沉淀充分搅拌重悬于 Buffer B中,离心取上清,缓慢加入硫酸铵粉末至饱和度为40%以盐析蛋白,室温静置 5~10min后25℃下12000rpm(×21235g)离心20min取沉淀,再将该沉淀悬于蒸馏水中,置于搅拌台上充分搅拌均匀后离心取上清。最后若需要完全纯水溶解的蛋白可选用疏水柱过滤该上清取流出液。纯化后的蛋白视存储需求进行冻干。纯化流程如图2所示。Step 2) Separation and purification after harvesting the fermented cells: fully resuspend the Escherichia coli wet cells expressing the fusion protein LL37-MaSpI in Buffer A at a mass-volume ratio of 1:10 to adjust the pH to Z, and then pass through a high-pressure homogenizer The high pressure of 800 ~ 1000bar breaks the wall to release intracellular substances. The pH of the broken bacteria solution after breaking the wall was adjusted to Z, and then the supernatant was discarded by centrifugation, and the precipitate was placed on a stirring table and stirred, so that it was fully resuspended in Buffer A, and then centrifuged at 12000rpm (×21235g) for 20min at 25°C to take the precipitate. The step plays the role of washing and is repeated 3 times in total. The precipitate after washing 3 times was fully stirred and resuspended in Buffer B. The supernatant was collected by centrifugation, and ammonium sulfate powder was slowly added until the saturation was 40% to salt out the protein. After standing at room temperature for 5-10 min, the pellet was kept at 12000 rpm (× 25°C). 21235g) centrifuge for 20 min to get the precipitate, then suspend the precipitate in distilled water, place it on a stirring table and stir well, and then centrifuge to get the supernatant. Finally, if the protein dissolved in completely pure water is required, the supernatant can be filtered with a hydrophobic column to obtain the effluent. The purified protein is lyophilized according to storage requirements. The purification process is shown in Figure 2.

在本实施例中,对于LL37-MaSpI16融合蛋白而言,Z=6.9,其计算方式为LL37等电点10.61×该融合蛋白在复合物中的含量40%+负电蛋白OmpF等电点4.5×该负电蛋白在复合物中的含量60%;对于protamine-MaSpI16融合蛋白而言,Z=6.1,其计算方式为protamine等电点12.48×该融合蛋白在复合物中的含量20%+负电蛋白OmpF等电点4.5×该负电蛋白在复合物中的含量80%。In this example, for the LL37-MaSpI16 fusion protein, Z=6.9, and its calculation method is LL37 isoelectric point 10.61 × the content of the fusion protein in the complex 40% + negatively charged protein OmpF isoelectric point 4.5 × this The content of negatively charged protein in the complex is 60%; for the protamine-MaSpI16 fusion protein, Z=6.1, which is calculated as the isoelectric point of protamine 12.48×the content of the fusion protein in the complex 20%+the negatively charged protein OmpF, etc. The electric point is 4.5×the content of the negatively charged protein in the complex is 80%.

所述的BufferA为含有10mM Tris和50mM NaCl的水溶液(pH=Z)。The Buffer A is an aqueous solution (pH=Z) containing 10 mM Tris and 50 mM NaCl.

所述的Buffer B含有50mM Tris,500mM NaCl,8M尿素,2%m/v的PEI10kd, 1.5%v/v的Triton X-100的水溶液(pH 4.5)。The Buffer B contained 50 mM Tris, 500 mM NaCl, 8 M urea, 2% m/v PEI 10kd , 1.5% v/v Triton X-100 in water (pH 4.5).

所述的BufferA调节pH至Z是为了让目的蛋白和负电杂蛋白OmpF的结合复合物在等电点处沉淀以达到粗纯作用,Buffer B中50mM Tris是为了缓冲pH的变化,500mM NaCl是为了竞争减弱目的蛋白和负电杂蛋白的静电相互作用,8M尿素是氢键、疏水相互作用的强破坏剂,让沉淀充分溶解,2%m/v的PEI10kd是为了结合负电杂蛋白将其沉降下来,1.5%v/v的TritonX-100是目的蛋白的促溶剂,pH 4.5是为了让所有杂蛋白进一步沉淀。The Buffer A adjusts the pH to Z in order to make the binding complex of the target protein and the negatively charged heteroprotein OmpF precipitate at the isoelectric point to achieve crude purity, 50mM Tris in Buffer B is for buffering pH changes, 500mM NaCl is for The competition weakens the electrostatic interaction between the target protein and the negatively charged heteroprotein. 8M urea is a strong destroyer of hydrogen bonds and hydrophobic interactions, so that the precipitate can be fully dissolved. 2% m/v PEI 10kd is used to bind the negatively charged heteroprotein to settle it down , 1.5% v/v TritonX-100 is the accelerant for the target protein, and pH 4.5 is to further precipitate all impurity proteins.

步骤3)获取高纯度冻干蛋白后制备水下粘附水凝胶:将冻干的蛋白少量多次逐渐加入 90mM LiBr溶液中,每次待加入的冻干粉末充分溶解后再行续加,直到配置为100mg/ml的蛋白溶液。将一定体积的该蛋白溶液逐渐滴加到等体积的200mg/ml单宁酸液中,边滴加边搅拌,制备时的溶液体积视水凝胶需求量大小而定,如5ml的蛋白溶液滴加入5ml单宁酸溶液可制得大约1cm直径的球状水凝胶,如图4所示。Step 3) Preparation of underwater adhesive hydrogel after obtaining high-purity freeze-dried protein: gradually add the freeze-dried protein to the 90 mM LiBr solution in small amounts and several times, and continue adding after the freeze-dried powder to be added is fully dissolved each time. Until the preparation is 100mg/ml protein solution. Gradually add a certain volume of the protein solution dropwise to an equal volume of 200mg/ml tannin solution, and stir while adding. Adding 5 ml of tannic acid solution can produce spherical hydrogels with a diameter of about 1 cm, as shown in Figure 4.

所述的溶解冻干蛋白粉的溶剂为LiBr溶液,且浓度为90mM。The solvent for dissolving the freeze-dried protein powder is LiBr solution, and the concentration is 90 mM.

所述的蛋白溶液浓度为100mg/ml。The concentration of the protein solution was 100 mg/ml.

所述的单宁酸溶液浓度为200mg/ml。The concentration of the tannic acid solution is 200 mg/ml.

所述的蛋白溶液和单宁酸溶液体积比为1:1。The volume ratio of the protein solution and the tannic acid solution is 1:1.

经过具体实际实验,在采用上述表达宿主细胞和按照上述分离纯化操作参数条件下,可在2h内快速完成纯化流程,将整个纯化流程时间缩短至亲和层析纯化的十分之一,纯化所得蛋白纯度高达90%以上,如图1所示。After specific practical experiments, under the conditions of using the above-mentioned expression host cells and according to the above-mentioned separation and purification operation parameters, the purification process can be quickly completed within 2 hours, and the time of the entire purification process can be shortened to one tenth of the purification by affinity chromatography. The purified protein The purity is as high as more than 90%, as shown in Figure 1.

经过具体实际实验,在蛋白浓度100mg/ml,单宁酸溶液浓度100~300mg/ml,蛋白溶液和单宁酸溶液体积比为1:1条件下,所得到的LL37-MaSpI16融合蛋白水凝胶水下粘附强度约为20~24kPa,对比MaSpI16在同等水凝胶制备使用条件下粘附强度提高了30%~100%; protamine-MaSpI16融合蛋白水凝胶水下粘附强度约为18~23kPa,对比MaSpI16在同等水凝胶制备使用条件下粘附强度提高了18%~50%,且无均其他粘附水凝胶中的非天然致毒成分,对组织器官表面和常见材料如塑料,金属等均具有快速,稳定的粘附性,如图8所示。After specific practical experiments, the obtained LL37-MaSpI16 fusion protein hydrogel was obtained under the condition that the protein concentration was 100 mg/ml, the tannic acid solution concentration was 100-300 mg/ml, and the volume ratio of protein solution and tannic acid solution was 1:1. The underwater adhesion strength is about 20~24kPa, which is 30%~100% higher than that of MaSpI16 under the same preparation and use conditions of the hydrogel; the underwater adhesion strength of the protamine-MaSpI16 fusion protein hydrogel is about 18~100%. 23kPa, compared with MaSpI16, the adhesion strength is increased by 18% to 50% under the same conditions of hydrogel preparation and use, and there is no non-natural toxic components in other adhesion hydrogels, which is harmful to the surface of tissues and organs and common materials such as plastics. , metals, etc. all have fast and stable adhesion, as shown in Figure 8.

上述具体实施可由本领域技术人员在不背离本发明原理和宗旨的前提下以不同的方式对其进行局部调整,本发明的保护范围以权利要求书为准且不由上述具体实施所限,在其范围内的各个实现方案均受本发明之约束。The above-mentioned specific implementation can be partially adjusted by those skilled in the art in different ways without departing from the principle and purpose of the present invention. The protection scope of the present invention is subject to the claims and is not limited by the above-mentioned specific implementation. Each implementation within the scope is bound by the present invention.

序列表sequence listing

<110> 上海交通大学<110> Shanghai Jiaotong University

<120> 基于蛛丝-阳离子多肽融合蛋白的纯化及水下粘附水凝胶的制备方法<120> Purification based on spider silk-cationic polypeptide fusion protein and preparation method of underwater adhesive hydrogel

<130> fxc850e<130> fxc850e

<141> 2022-03-09<141> 2022-03-09

<160> 5<160> 5

<170> SIPOSequenceListing 1.0<170> SIPOSequenceListing 1.0

<210> 1<210> 1

<211> 31<211> 31

<212> PRT<212> PRT

<213> MaSpI核心重复序列(Trichonephila clavipes)<213> MaSpI core repeat (Trichonephila clavipes)

<400> 1<400> 1

Gly Arg Gly Gly Leu Gly Gly Gln Gly Ala Gly Ala Ala Ala Ala AlaGly Arg Gly Gly Leu Gly Gly Gln Gly Ala Gly Ala Ala Ala Ala Ala

1 5 10 151 5 10 15

Gly Gly Ala Gly Gln Gly Gly Tyr Gly Gly Leu Gly Ser Gln GlyGly Gly Ala Gly Gln Gly Gly Tyr Gly Gly Leu Gly Ser Gln Gly

20 25 30 20 25 30

<210> 2<210> 2

<211> 37<211> 37

<212> PRT<212> PRT

<213> 阳离子多肽LL37(Artificial Sequence)<213> Cationic polypeptide LL37 (Artificial Sequence)

<400> 2<400> 2

Leu Leu Gly Asp Phe Phe Arg Lys Ser Lys Glu Lys Ile Gly Lys GluLeu Leu Gly Asp Phe Phe Arg Lys Ser Lys Glu Lys Ile Gly Lys Glu

1 5 10 151 5 10 15

Phe Lys Arg Ile Val Gln Arg Ile Lys Asp Phe Leu Arg Asn Leu ValPhe Lys Arg Ile Val Gln Arg Ile Lys Asp Phe Leu Arg Asn Leu Val

20 25 30 20 25 30

Pro Arg Thr Glu SerPro Arg Thr Glu Ser

35 35

<210> 3<210> 3

<211> 111<211> 111

<212> DNA<212> DNA

<213> LL37密码子优化后序列(Artificial Sequence)<213> LL37 codon-optimized sequence (Artificial Sequence)

<400> 3<400> 3

ctgctgggcg atttcttccg caaaagcaaa gaaaaaatcg gcaaagaatt caaacgcatc 60ctgctgggcg atttcttccg caaaagcaaa gaaaaaatcg gcaaagaatt caaacgcatc 60

gttcagcgca tcaaagattt cctgcgcaat ctggttccgc gcaccgaaag c 111gttcagcgca tcaaagattt cctgcgcaat ctggttccgc gcaccgaaag c 111

<210> 4<210> 4

<211> 22<211> 22

<212> PRT<212> PRT

<213> protamine多肽(Artificial Sequence)<213> protamine polypeptide (Artificial Sequence)

<400> 4<400> 4

Arg Ser Gln Ser Arg Ser Arg Tyr Tyr Arg Gln Arg Gln Arg Ser ArgArg Ser Gln Ser Arg Ser Arg Tyr Tyr Arg Gln Arg Gln Arg Ser Arg

1 5 10 151 5 10 15

Arg Arg Arg Arg Arg SerArg Arg Arg Arg Arg Ser

20 20

<210> 5<210> 5

<211> 66<211> 66

<212> DNA<212> DNA

<213> protamine密码子优化后序列(Artificial Sequence)<213> protamine codon-optimized sequence (Artificial Sequence)

<400> 5<400> 5

cgtagccaga gccgtagccg ttactaccgt cagcgtcagc gtagccgtcg tcgtcgccgt 60cgtagccaga gccgtagccg ttactaccgt cagcgtcagc gtagccgtcg tcgtcgccgt 60

cgtagc 66cgtagc 66

Claims (9)

1. A preparation method of underwater adhesion hydrogel based on spider silk-cationic polypeptide fusion protein is characterized in that gene fusion of recombinant spider silk protein gene and cationic polypeptide is connected to an expression vector pET28a4 to construct a recombinant expression vector, then the recombinant expression vector is introduced into an expression host cell, and high-purity protein is obtained after fermentation expression, separation and purification; then, carrying out cross-linking reaction on the high-purity mesh protein solution and a tannic acid solution to obtain underwater adhesive hydrogel;
the recombinant spider silk protein gene refers to: a protein of the silkworms (trichoneephila clavipes) dragline protein MaSpI core repeat repeated 4, 8, 16, 32 and 64 times, wherein: the amino acid sequence of the MaSpI core repetitive sequence is shown as SEQ ID No. 1;
the separation and purification, the combination of the positive electricity block of the recombinant spider silk protein and the negative electricity OmpF membrane protein, the pH value is adjusted to the isoelectric point Z of the combination to ensure that the combination is precipitated and coarse, the combination is dissolved in Buffer B after being rinsed, the strong positive charge of PEI in the Buffer B is combined with the negative electricity ompF protein to ensure that the combination is precipitated, and the recombinant spider silk protein still exists in the supernatant to realize further purification.
2. The method according to claim 1, wherein the constructing comprises: the synthesized cationic polypeptide gene was digested by restriction endonucleases BamHI HF and NcoIHF, and ligated to expression vector pET28a4 by T4 DNA ligase to obtain an expression vector of recombinant spidroin.
3. The method of claim 1 or 2, wherein the cationic polypeptide comprises: LL37, protamine polypeptides, polylysine, polyarginine, polyhistidine, lysine-rich, arginine-rich, histidine-rich, and like positively charged polypeptides.
4. The method according to claim 3, wherein the amino acid sequence of LL37 is shown in SEQ ID No.2, i.e.: LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES, the nucleotide sequence of which after codon optimization is shown in SEQ ID No.3, namely: 5'-CTGCTGGGCGATTTCTTCCGCAAAAGCAAAGAAAAAATCGGCAAAGAATTCAAACGCATCGTTCAGCGCATCAAAGATTTCCTGCGCAATCTGGTTCCGCGCACCGAAAGC-3', respectively;
the amino acid sequence of the protamine polypeptide is shown as SEQ ID No.4, namely: RSQSRSRYYRQRQRSRRRRRRS (from database: NCBI), having a codon-optimized nucleotide sequence as shown in SEQ ID No.5, namely: 5'-CGTAGCCAGAGCCGTAGCCGTTACTACCGTCAGCGTCAGCGTAGCCGTCGTCGTCGCCGTCGTAGC-3' are provided.
5. The method according to claim 1, wherein the expression hosts are E.coli BL21(DE3) and E.coli BL21(DE3) plysS, and the protein expression inducer is isopropyl thiogalactoside (IPTG).
6. The method according to claim 1, wherein the separation and purification comprises: e.coli wet cells expressing the fusion protein were cultured in a manner of 1: fully suspending the mixture in a Buffer A at a mass-volume ratio of 10, and breaking the walls by using a high-pressure homogenizer at a high pressure of 800-1000 bar to release intracellular substances; broken fungus liquid after will breaking the wall adjusts pH to Z, the isoelectric point of the negative electricity membrane protein OmpF that has fused polypeptide Y's recombination spider silk protein and broken fungus release combines the complex promptly, use magnetic stirrers stirring 30min, centrifugation is abandoned the supernatant and is got the deposit and resuspend in Buffer A again afterwards, abundant resuspension washing is repeated 3 times, will deposit abundant resuspending in Buffer B centrifugation after the centrifugation and get the supernatant, carry out the ammonium sulfate sediment with the supernatant, resuspend this deposit in distilled water again, the supernatant is got in the centrifugation, the protein that dissolves if needs complete pure water can select for use this supernatant to filter the outflow if at last.
7. The method according to claim 6, wherein the isoelectric point Z is the isoelectric point of the polypeptide Y x the content thereof in the complex + OmpF isoelectric point 4.5 x the content thereof in the complex;
the Buffer A is an aqueous solution containing 10mM Tris and 50mM NaCl, and the pH value of the Buffer A is the same as the isoelectric point value Z;
the Buffer B contains 50mM Tris, 500mM NaCl, 8M urea and PEI 10kd (2% m/v) Triton X-100 (1.5% v/v) in water (pH 4.5);
the ammonium sulfate precipitation specifically comprises the following steps: ammonium sulfate powder was added to the supernatant to 40% saturation, at which time the protein solution would aggregate and precipitate, and the precipitate was removed by centrifugation at 12000rpm (X21235 g) for 30min at 25 ℃.
8. The method of claim 1, wherein the solution of the high purity target protein is: dissolving the freeze-dried protein in a 90mM LiBr solution to prepare a 100mg/ml protein solution;
the crosslinking reaction is as follows: according to the following steps: gradually dropwise adding the solution of the high-purity protein into the tannic acid solution in a volume ratio of 1, and stirring by using a stirring rod after dropwise adding is finished to form the hydrogel adhered to the stirring rod.
9. An underwater adhesive hydrogel prepared by the method according to any one of claims 1 to 8, wherein the hydrogel is a soft and moldable light brown solid with abundant pore structures and the underwater adhesive strength is 1 to 100 kpa.
CN202210230688.7A 2022-03-09 2022-03-09 Purification of spider silk-cationic peptide fusion protein and preparation method of underwater adhesive hydrogel Active CN114805847B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202210230688.7A CN114805847B (en) 2022-03-09 2022-03-09 Purification of spider silk-cationic peptide fusion protein and preparation method of underwater adhesive hydrogel

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210230688.7A CN114805847B (en) 2022-03-09 2022-03-09 Purification of spider silk-cationic peptide fusion protein and preparation method of underwater adhesive hydrogel

Publications (2)

Publication Number Publication Date
CN114805847A true CN114805847A (en) 2022-07-29
CN114805847B CN114805847B (en) 2024-03-19

Family

ID=82529538

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210230688.7A Active CN114805847B (en) 2022-03-09 2022-03-09 Purification of spider silk-cationic peptide fusion protein and preparation method of underwater adhesive hydrogel

Country Status (1)

Country Link
CN (1) CN114805847B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118531517A (en) * 2024-05-21 2024-08-23 上海交通大学 Preparation method and application of underwater drivable fiber based on recombinant spider silk protein

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1450169A (en) * 2003-05-08 2003-10-22 福建师范大学 Separation purification method for preparing sex-gene recombination spider dragline silk protein
CN104725497A (en) * 2013-12-19 2015-06-24 天津耀宇生物技术有限公司 Bombyx mori main assistant transport protein BmMFS, fusion expression and purification method thereof
CN105031723A (en) * 2015-06-23 2015-11-11 上海交通大学 Thermosensitive hydrogel based on spider silk protein
WO2019242047A1 (en) * 2018-06-22 2019-12-26 常州京森生物医药研究所有限公司 Recombinant spider silk proteins, preparation method therefor and industrial application thereof
CN110684208A (en) * 2018-07-05 2020-01-14 中国科学院青岛生物能源与过程研究所 A kind of preparation method of high mechanical strength spider silk protein-collagen composite hydrogel

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1450169A (en) * 2003-05-08 2003-10-22 福建师范大学 Separation purification method for preparing sex-gene recombination spider dragline silk protein
CN104725497A (en) * 2013-12-19 2015-06-24 天津耀宇生物技术有限公司 Bombyx mori main assistant transport protein BmMFS, fusion expression and purification method thereof
CN105031723A (en) * 2015-06-23 2015-11-11 上海交通大学 Thermosensitive hydrogel based on spider silk protein
WO2019242047A1 (en) * 2018-06-22 2019-12-26 常州京森生物医药研究所有限公司 Recombinant spider silk proteins, preparation method therefor and industrial application thereof
CN110684208A (en) * 2018-07-05 2020-01-14 中国科学院青岛生物能源与过程研究所 A kind of preparation method of high mechanical strength spider silk protein-collagen composite hydrogel

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
FANG LUO ET AL.: "Responsive Protein Hydrogels Assembled from Spider Silk Carboxyl-Terminal Domain and Resilin Copolymers", 《POLYMERS》, 14 August 2018 (2018-08-14) *
SHAO-PENG WEI ET AL.: "Formation and functionalization of membraneless compartments in Escherichia coli.", 《NATURE CHEMICAL BIOLOGY》, 29 June 2020 (2020-06-29) *
李敏, 黄建坤, 涂桂云, 黄曦: "RGD-蜘蛛拖丝蛋白聚合物的生物合成与纯化", 生物医学工程学杂志, no. 06, 30 December 2004 (2004-12-30) *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118531517A (en) * 2024-05-21 2024-08-23 上海交通大学 Preparation method and application of underwater drivable fiber based on recombinant spider silk protein
CN118531517B (en) * 2024-05-21 2025-03-07 上海交通大学 Preparation method and application of underwater drivable fiber based on recombinant spider silk protein

Also Published As

Publication number Publication date
CN114805847B (en) 2024-03-19

Similar Documents

Publication Publication Date Title
US20210163576A1 (en) Preparation Method for Collagen Hydrogel
US6620917B1 (en) Method for the purification and aqueous fiber spinning of spider silks and other structural proteins
CN1163600C (en) The preparation method of human proinsulin
WO2024001242A1 (en) Polypeptide and use thereof
CN112575016B (en) Construction and application of membrane-free organelle in prokaryotes
WO2019163871A1 (en) Fusion protein
CN108456246B (en) Recombinant spider silk protein, preparation method and application thereof
WO2005111068A2 (en) A method for purifying and recovering silk proteins using magnetic affinity separation
US10913777B2 (en) In vitro assembly of bacterial microcompartments
WO2022052368A1 (en) Novel proinsulin glargine and method for preparing insulin glargine therefrom
CN107446941A (en) Cecropin A antibacterial peptide based on self-aggregation short-peptide induction and preparation method thereof
US10000544B2 (en) Process for production of insulin and insulin analogues
CN114805847A (en) Purification based on spider silk-cationic polypeptide fusion protein and preparation method of underwater adhesion hydrogel
Riley et al. Bioproduction and characterization of a pH responsive self‐assembling peptide
CN104017089A (en) Ferritin heavy-chain subunit nanoparticles, and preparation method and application thereof
CN105031723B (en) Thermosensitive hydrogel based on spider silk protein
KR101551143B1 (en) Biocompatible protein, biocompatible protein gel and biocompatible conductive protein gel comprising the protein and preparing method thereof
WO2020258372A1 (en) Thioredoxin mutant, preparation method thereof, and application thereof in production of recombinant fusion protein
CN106755042B (en) A method for preparing bioactive small peptides based on combined self-cleavage and protein scaffolds
CN114480269A (en) Recombinant protein hydrogel culture scaffold and preparation method thereof
CN105085685B (en) A kind of MRRP albumen, gene, carrier, engineering bacteria and its application
CN118620091A (en) A series of semaglutide core 29 peptide fusion molecules based on Escherichia coli expression system and their applications
CN108728472A (en) The preparation method of class segmental appendage fibroin block copolymer and its hydrogel
CN116496365B (en) Acidic surface-assisted dissolution short peptide tag for improving recombinant protein expression efficiency
CN113004419B (en) Preparation method of procalcitonin

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant